No Association Between AGT Gene Polymorphisms with Hypertension in a South African Population
Jyoti Sharma,Hannah Fokkens,Ria Laubscher,Teke Apalata,Sibusiso Nomatshila,Samuel Alomatu,Hans Strijdom,Rabia Johnson
DOI: https://doi.org/10.2147/dmso.s452272
2024-04-30
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Jyoti Rajan Sharma, 1, &ast Hannah Fokkens, 1, 2, &ast Ria Laubscher, 3 Teke Ruffin Apalata, 4 Sibusiso Cyprian Nomatshila, 5 Samuel Yao Alomatu, 6 Hans Strijdom, 2 Rabia Johnson 1, 2 1 Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa; 2 Centre for Cardiometabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; 3 Biostatistics Research Unit, South African Medical Research Council, Cape Town, South Africa; 4 Department of Laboratory-Medicine and Pathology, Faculty of Health Sciences, Walter Sisulu University and National Health Laboratory Services, Mthatha, South Africa; 5 Department of Public Health, Faculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha, South Africa; 6 Department of Internal Medicine, Nelson Mandela Central Hospital and Walter Sisulu University, Mthatha, South Africa &astThese authors contributed equally to this work Correspondence: Rabia Johnson, Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, Cape Town, South Africa, Email Purpose: Hypertension is a leading cause of cardiovascular-related morbidity and mortality worldwide, with a prevalence increasing at an alarming rate in both middle- and low-income countries. Various environmental and genetic factors have been attributed to play a significant role in the increasing prevalence of hypertension. Single nucleotide polymorphisms (SNPs) in the angiotensinogen ( AGT ) gene are reported to have a significant association with hypertension; however, there are limited studies done on South African populations. Therefore, this case–control study aimed to investigate the association between AGT SNPs (rs2004776, rs3789678, rs5051 and rs7079) with hypertension in a study population of isiXhosa-speaking participants from the Eastern Cape Province in South Africa. Materials and Methods: The SNPs were genotyped in 250 hypertensive cases and 237 normotensive controls, using TaqMan genotyping assays. Results: For the SNP rs2004776, the frequency of CC genotype (18.4%) and C allele (44%) in hypertensive cases showed no significant differences (p = 0.52, χ 2 = 1.32), when compared to the normotensive control group (CC: 19.8% and C allele: 43%). Similar results were obtained for the genotypic and allelic frequencies between hypertensive cases and normotensive controls for rs3789678 (p = 0.88, χ 2=0.26) and rs5051 (p = 0.57, χ 2=1.12), and rs7079 (p = 0.33, χ 2=2.23). These findings demonstrate that there were no significant associations between the SNPs rs2004776, rs3789678, rs7079, rs5051 with hypertension in our study population. Conclusion: These findings suggest that AGT gene polymorphisms are not associated with the development of hypertension in the studied population. The present study represents the first genetic report to investigate the AGT gene polymorphisms with hypertension in an isiXhosa-speaking South African population. Keywords: hypertension, gene, ACE, AGT, polymorphism Cardiovascular diseases (CVD) are the leading cause of deaths globally, accounting for 19.8 million deaths worldwide in 2022. 1–3 Hypertension drives the global burden of CVD and is a leading cause of cardiovascular-related mortality worldwide, with 1.39 billion affected adults and 10.4 million deaths globally. 4–6 It has emerged as a major public health issue in sub-Saharan Africa, contributing to the region's rising number of early deaths. In South Africa, hypertension has an estimated prevalence of 27–58% and is referred as a "silent killer", with 46% of adults being oblivious of their hypertension status. 7–11 The prevalence of hypertension in the rural communities is even higher. According to Sharma et al, 12 the prevalence of hypertension is 71% in the rural community of Mthatha town in Eastern Cape province, South Africa. Previously, other studies have also highlighted the serious concern of escalating prevalence of hypertension in rural South Africa. 13–15 Despite having an advanced understanding of the pathogenesis and the management of hypertension, there is still a progressive rise in its prevalence. 16 Various factors, including environmental and genetic factors, have been attributed to play a significant role in the increasing prevalence of hypertension. 12,17–19 Although the exact role of the genetic factors in the regulation of hypertension is still unkn -Abstract Truncated-
endocrinology & metabolism